Core C -Centralized Laboratory Support Core
核心C - 集中实验室支持核心
基本信息
- 批准号:10609765
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-08 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeBioinformaticsBiological AssayBiological MarkersBloodBlood CellsCLIA certifiedClinicalClinical ResearchCommunitiesComputer AnalysisConsultationsDNADedicationsDiagnosticDisease remissionEducationEnzyme-Linked Immunosorbent AssayFundingGenomeGenomicsGoalsGrantHIVHIV-1HIV/AIDSHumanImmune responseImmunoassayImmunologyImmunology procedureInfectionInterdisciplinary StudyLaboratoriesLaboratory StudyLinkLos AngelesMeasurementMentorsModelingMucous MembraneNeeds AssessmentPlasmaProteomeProteomicsPublicationsRNAReportingResearchResearch DesignResearch PersonnelResourcesScienceScientistServicesShotgunsSpecimenTechniquesTechnologyTissuesTrainingTraining and EducationUmbilical Cord BloodViral Load resultWorkcomplex datacost effectivecytokinedesigninnovationinterestlecturesmetabolomemetabolomicsmetagenomic sequencingmicrobiomemicrobiome sequencingmultidisciplinarynew technologynext generation sequencingnovelprogramsresponsetoolvirology
项目摘要
Core C: Project Summary/Abstract: A major focus of the UCLA-CDU Center for AIDS Research (CFAR) is
facilitation of multidisciplinary science to advance research in HIV prevention, treatment, and ART-free
remission. The Centralized Laboratory Support Core functions to provide investigators with a one-stop center for
consultation and access to laboratory assays, cutting-edge technologies, and expertise to support innovative,
multidisciplinary research. Laboratory services include assays focused on virology, immunology, and `omics'
technologies including microbiome. In addition, this Core provides novel access to valuable human blood and
mucosal specimens. These services enable timely and cost-effective access to these assays and tissues, which
would be otherwise unattainable for many CFAR investigators. The Core will also work to develop new assays
and research tools in response to the scientific interests of its users. The Core will also offer CAP/CLIA-certified
laboratory services to support advancement of clinical research. Finally, the Core will also provide important
training and education services to keep the CFAR community up to date on the latest technologies and
specifically support early stage investigators in the transition to independence. Specifically, we propose to: 1)
Facilitate basic and translational HIV/AIDS research through comprehensive laboratory services to assess HIV-
1 infection and immune responses; 2) Provide expertise in the design, implementation, and analysis of studies
examining HIV-1 and the microbiome, metabolome, or proteome; 3) Support clinical research on HIV prevention,
treatment, and ART-free remission through CAP/CLIA-certified laboratory services; and 4) Support and stimulate
translational HIV/AIDS research by providing mentoring, training, and education programs in relevant laboratory
techniques.
核心C:项目摘要/摘要:加州大学洛杉矶分校-CDU艾滋病研究中心(CFAR)的一个主要重点是
促进多学科科学促进艾滋病毒预防、治疗和无ART研究
缓解。集中实验室支持核心功能为研究者提供一站式中心,
咨询和获得实验室分析,尖端技术和专业知识,以支持创新,
多学科研究。实验室服务包括侧重于病毒学、免疫学和“组学”的分析
包括微生物组在内的技术。此外,该核心提供了获得宝贵人类血液的新途径,
粘膜标本。这些服务使人们能够及时、经济高效地获得这些化验和组织,
这对许多CFAR调查人员来说是无法实现的。核心还将致力于开发新的检测方法
和研究工具,以满足其用户的科学兴趣。核心还将提供CAP/CLIA认证
实验室服务,以支持临床研究的进步。最后,核心还将提供重要的
培训和教育服务,使CFAR社区了解最新技术,
特别是在向独立过渡的早期阶段为调查人员提供支助。具体而言,我们建议:1)
通过全面的实验室服务促进艾滋病毒/艾滋病的基础和转化研究,以评估艾滋病毒-
1感染和免疫反应; 2)提供研究设计,实施和分析方面的专业知识
检查HIV-1和微生物组、代谢组或蛋白质组; 3)支持HIV预防的临床研究,
通过CAP/CLIA认证的实验室服务进行无ART治疗和缓解;以及4)支持和激励
通过在相关实验室提供指导、培训和教育计划,开展转化型艾滋病毒/艾滋病研究
技术.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Grace M Aldrovandi其他文献
Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: A cross-sectional study
孕妇和非孕妇宫颈阴道分泌物中的免疫调节因子:横断面研究
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:3.7
- 作者:
Jan Walter;Linda Fraga;Melanie J Orin;William D Decker;Theresa Gipps;Alice Stek;Grace M Aldrovandi - 通讯作者:
Grace M Aldrovandi
Grace M Aldrovandi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Grace M Aldrovandi', 18)}}的其他基金
Study of Tecovirimat for Human Monkeypox Virus (STOMP)
Tecovirimat 针对人猴痘病毒 (STOMP) 的研究
- 批准号:
10689623 - 财政年份:2022
- 资助金额:
$ 19万 - 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
- 批准号:
9920737 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
- 批准号:
10610833 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
Effects of Human Milk Oligosaccharides and Gut Microbiome on Growth and Morbidity in HIV-Exposed Uninfected Infants
母乳低聚糖和肠道微生物组对暴露于 HIV 的未感染婴儿生长和发病的影响
- 批准号:
10382305 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents
成熟、传染性和创伤(麻省理工学院)导致青少年对艾滋病毒的易感性
- 批准号:
9245320 - 财政年份:2017
- 资助金额:
$ 19万 - 项目类别:
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
国际孕产妇儿科青少年艾滋病临床试验(IMPAACT)实验室中心
- 批准号:
9317270 - 财政年份:2016
- 资助金额:
$ 19万 - 项目类别:
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
国际孕产妇儿科青少年艾滋病临床试验(IMPAACT)实验室中心
- 批准号:
9188522 - 财政年份:2016
- 资助金额:
$ 19万 - 项目类别:
International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network
国际孕产妇、青少年和儿科治疗临床试验网络
- 批准号:
9986166 - 财政年份:2014
- 资助金额:
$ 19万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 19万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 19万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 19万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 19万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 19万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 19万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 19万 - 项目类别:














{{item.name}}会员




